Key takeaways

  • Screening in India is a sequence, not one test: a dating scan, an NT scan with double marker (11–13⁺⁶ weeks), an optional NIPT from 10 weeks, and the level-2 anomaly scan (TIFFA) at 18–22 weeks, which FOGSI treats as essential in every pregnancy.
  • Screening tests give a probability, not a diagnosis. A high-risk result needs confirmation with a diagnostic test (CVS or amniocentesis) before any major decision.
  • Soft markers are common anatomical variants. An isolated soft marker on an otherwise normal scan usually doesn't change anything — it is not a diagnosis and not a reason to panic.
  • NIPT is the most accurate non-invasive screen (about 99% detection for Down syndrome) but it is still a screen, not a confirmation.
  • Folic acid before conception prevents most neural tube defects — the single highest-yield thing you can do.
  • By law (PC-PNDT Act), no test or scan in India may reveal the baby's sex. Compliant clinics never disclose it.

Birth Defects in India: How Common, Which Ones, and Why Screening Matters

About 1.7–2% of Indian babies are born with a congenital anomaly — hundreds of thousands of newborns every year. The most common categories are structural heart defects (the single largest group), neural tube defects such as spina bifida and anencephaly, chromosomal conditions led by Down syndrome (trisomy 21) and the rarer trisomies 18 and 13, and inherited single-gene disorders led by thalassemia and sickle cell disease. Some are mild and fully treatable, some need major surgery in the newborn period, and a small minority are not survivable.

The point of screening is not to find a reason to end pregnancies. It is to identify a problem early enough that a family can prepare — plan delivery at a hospital with the right paediatric and surgical support, arrange specialist neonatal care, or, where a severe anomaly is confirmed within the legal window, consider a difficult decision with proper counselling and a clear legal process.

Regional patterns matter in India. Thalassemia carrier rates run at roughly 3–4% nationally, but can exceed 10% in some Sindhi, Gujarati, Punjabi and Bengali communities — which is why hemoglobinopathy screening (HPLC) is recommended at the first antenatal visit for both partners, especially in these groups. Sickle cell disease is concentrated in tribal populations of central India, and neural tube defect rates are higher where pre-conception folic acid uptake is poor. Your community background and family history shape the screening pathway your OB-GYN recommends; if both partners may carry a hemoglobinopathy, read our guide to thalassemia carrier screening for Indian couples.

Access has improved. Most women can reach at least the core pathway — through the Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA), which offers a free check at government facilities on the 9th of every month, through Ayushman Bharat (PMJAY) at empanelled tertiary centres, or through private hospitals and labs. The Rashtriya Bal Swasthya Karyakram (RBSK) extends screening after birth, catching defects not found antenatally.

The Antenatal Screening Schedule, 8 to 22 Weeks

The schedule is fairly standard across government and private settings, with small variations in which optional tests are offered. Knowing the sequence ahead of time makes each appointment far less stressful — you can also follow it alongside our week-by-week pregnancy guide.

The first scan, the dating scan, happens at 8–10 weeks. It confirms a viable pregnancy inside the uterus, dates it accurately from the crown-rump length, and identifies twin or higher-order pregnancies. From 11 to 13 weeks plus 6 days, the NT scan measures the nuchal translucency at the back of the baby's neck, checks the nasal bone and assesses blood flow in the ductus venosus; combined with the double marker blood test (PAPP-A and free beta-hCG) drawn the same day, this gives a risk estimate for trisomies 21, 18 and 13.

If the early-trimester screen is missed, a quadruple marker (AFP, hCG, unconjugated estriol, inhibin-A) at 15–20 weeks gives a second-trimester chromosomal screen and also screens for neural tube defects through the AFP component. NIPT, the cell-free fetal DNA test, can be done from 10 weeks and is the most accurate single chromosomal screen available.

The single most important scan of the whole pregnancy, structurally, is the level-2 anomaly scan — also called TIFFA (targeted imaging for fetal anomalies) — done at 18–22 weeks. It systematically examines every organ system. FOGSI's antenatal guidelines treat it as essential in every pregnancy, and almost every detectable structural anomaly is found on this one scan. Costs range from about ₹500 at a government facility to ₹5,000 at a premium private centre, usually with same-day results.

NT Scan and Double Marker at 11–13 Weeks

The NT scan and double marker together form India's standard first-trimester chromosomal screen. Timing is strict: the measurement is valid only between 11 weeks and 13 weeks plus 6 days, when the crown-rump length is 45–84 mm. Outside this window it loses its predictive value, so it's worth booking the 12-week scan window precisely.

The nuchal translucency is the small fluid space at the back of the baby's neck. A thickness above the 95th percentile for gestational age (often quoted as above 3.5 mm) raises the probability of a chromosomal condition or a major structural heart defect. The scan also notes whether the nasal bone is present and checks ductus venosus flow — both feed into the combined risk.

The double marker is a simple maternal blood test measuring two placental proteins: pregnancy-associated plasma protein A (PAPP-A) and the free beta subunit of hCG. The lab software combines the biochemistry with the NT measurement, maternal age and gestational age into a single risk number, usually a ratio (for example, 1 in 250 for trisomy 21). A result above the cut-off — commonly 1 in 250 or 1 in 270, depending on the lab — is reported as high-risk and triggers an offer of NIPT or, if the risk is very high, of diagnostic confirmation.

Cost ranges from about ₹500 at government PMSMA facilities to ₹4,000 privately. Detection for trisomy 21 is around 80–85%, with a false-positive rate of about 5%. It's a useful, accessible first screen — but less accurate than NIPT for the same conditions. The choice between them often comes down to cost and to how much an early, high-accuracy result matters to a family.

The Level-2 Anomaly Scan (TIFFA) at 18–22 Weeks

If you do nothing else in your pregnancy, do the anomaly scan. The level-2 anomaly scan at 18–22 weeks is the single most important structural screen of pregnancy, and FOGSI treats it as essential. A trained fetal medicine sonologist examines the head and brain (lateral ventricles, cerebellum, posterior fossa), face and lip (cleft lip), spine (a full sweep for neural tube defects), heart and great vessels (a detailed four-chamber and outflow-tract view that picks up most major heart defects), abdomen (stomach, kidneys, bladder, abdominal wall), limbs (long-bone measurements, counting digits), placenta and amniotic fluid. Done properly, it takes 30–45 minutes — for the full detail, see our dedicated guide to the TIFFA anomaly scan in India.

Most major structural anomalies — anencephaly, large encephaloceles, severe ventriculomegaly, cleft lip, major spina bifida, large heart defects, gastroschisis, renal agenesis, limb reduction defects — are detected here. Some subtle defects can be missed (very small ventricular septal defects, tiny spina bifida lesions), and some only appear later in pregnancy (growth restriction, progressive ventriculomegaly). The scan also picks up the soft markers discussed below.

Cost ranges from about ₹500 at government and PMSMA facilities to ₹5,000 at premium private fetal medicine centres. If a major anomaly is found, the standard pathway is referral to a fetal medicine specialist for a targeted review, paediatric cardiology assessment for any cardiac finding, genetic counselling, and a clear discussion of prognosis and options. Where a confirmed severe anomaly leads a family to consider termination, the legal framework is the Medical Termination of Pregnancy (MTP) Act, which allows termination up to 24 weeks on substantial fetal abnormality grounds, with a Medical Board's approval beyond 20 weeks.

NIPT: The Most Accurate Non-Invasive Chromosomal Screen

NIPT (non-invasive prenatal testing) is a maternal blood test that analyses cell-free fetal DNA fragments shed from the placenta into the mother's bloodstream. It can be done from 10 weeks and gives a detection rate of about 99% for trisomy 21, around 97% for trisomy 18 and around 90% for trisomy 13, with very low false-positive rates. It also screens sex-chromosome aneuploidies, and many panels add optional microdeletion screening — though accuracy for microdeletions is much lower and false positives much higher.

Cost in Indian labs ranges from about ₹15,000 for a basic trisomy-only panel to ₹35,000 for a premium whole-chromosome panel with microdeletions. NIPT is offered through major labs and fetal-medicine networks across the country; insurance rarely covers it unless the pregnancy is documented as high-risk, so most families pay out of pocket. Our detailed breakdown of NIPT cost and accuracy in India compares panels and providers, and our companion NIPT explainer covers what a positive result really means.

NIPT is most strongly indicated for advanced maternal age (35 or older), an abnormal NT scan or double marker, a previous pregnancy with a chromosomal abnormality, a family history of a genetic disorder, IVF pregnancies, and twin pregnancies — which carry their own monitoring considerations covered in our twin and multiple pregnancy guide. It is also a reasonable elective choice for anyone with no specific risk factor who simply wants the reassurance of an early, high-accuracy screen.

The crucial point: NIPT is a screening test, not a diagnostic one. A high-risk NIPT result always needs confirmation with CVS or amniocentesis before any major decision about the pregnancy.

When Diagnosis Is Needed: CVS and Amniocentesis

If a screening test (double marker, quadruple marker or NIPT) comes back high-risk, or if the anomaly scan shows a finding that strongly suggests a chromosomal condition, the next step may be a diagnostic test. Unlike screening tests, which give a probability, diagnostic tests sample fetal cells directly and give a definitive yes-or-no answer. The two main options are chorionic villus sampling (CVS) and amniocentesis.

CVS is performed at 10–13 weeks. Under continuous ultrasound guidance, a fine needle takes a small sample of placental tissue — through the abdomen or the cervix, depending on placental position. The cells have the same chromosomal make-up as the baby, and results come in about 7–14 days. The procedure-related miscarriage risk in experienced hands is about 0.2%. Cost ranges from ₹8,000 to ₹25,000. Our guide to CVS in Indian pregnancy explains when it's chosen over amniocentesis.

Amniocentesis is performed from 15 weeks, most commonly at 16–20 weeks. A fine needle, again under ultrasound guidance, withdraws a small volume of amniotic fluid through the abdominal wall; the fluid contains fetal cells for chromosomal analysis. Results take about 7–14 days for chromosomal microarray and 2–3 weeks for a full karyotype. The procedure-related miscarriage risk in experienced hands is about 0.1%, slightly lower than CVS. Cost ranges from ₹6,000 to ₹15,000. See our full guide to amniocentesis in India for what the day looks like.

Both procedures require informed consent and are offered only after counselling. They are never done casually — they exist for situations where a screening result or scan finding makes definitive confirmation important enough to justify the small procedural risk.

Soft Markers on Ultrasound: What They Are and What They Are Not

If your scan report mentions a "soft marker," take a breath first. Soft markers are ultrasound findings that are not, in themselves, abnormalities — they are anatomical variants that occur commonly in perfectly healthy babies but are found slightly more often in babies with chromosomal conditions.

The ones you're most likely to see on an anomaly scan are an echogenic intracardiac focus (a small bright spot in the heart muscle), a choroid plexus cyst (a small fluid-filled cyst in the brain's choroid plexus), mild renal pyelectasis (slight dilatation of the kidney collecting system), echogenic bowel (bowel appearing brighter than usual), a slightly short femur or humerus, and a single umbilical artery (the cord normally has two arteries and one vein; occasionally there's only one artery).

An isolated soft marker — the only finding on an otherwise normal scan — usually doesn't change the clinical picture meaningfully. Most babies with an isolated echogenic intracardiac focus or an isolated choroid plexus cyst are entirely normal, and the cysts in particular almost always resolve on their own by 24–28 weeks. The slight increase in chromosomal risk from a single soft marker is small, and many fetal medicine units don't change their plan beyond noting it and reviewing later. Multiple soft markers together raise the prior probability more substantially, and then an offer of NIPT or amniocentesis may be appropriate.

What soft markers are not is a diagnosis. They don't mean the baby has a condition; they nudge the prior probability up or down. The right response is calm interpretation in context — what other findings are present, what the screening biochemistry or NIPT shows, the maternal age and baseline risk — followed by a clear plan. That plan may be simply continued routine care, a repeat scan in a few weeks, or further testing if the overall picture warrants it. A soft marker is not, by itself, a reason to panic, and not, by itself, a reason for any major decision about the pregnancy.

Genetic Counselling in India: Where, When and What It Costs

Genetic counselling is the structured conversation that helps a family understand what a high-risk screening result, an abnormal scan finding, a positive carrier test or a family history actually means in practical terms — the probability of the condition, the spectrum of severity, what diagnostic tests can and cannot do, what management exists after birth, and what the legal and personal options are during the pregnancy. It is not advice on what to do; it's a structured exploration of what you want to know and what choices are available, so decisions are made with full understanding. Our guide to prenatal genetic counselling in India walks through a typical session.

Qualified genetic counsellors are available at major academic and tertiary centres — including AIIMS Delhi and its newer satellite institutes, KEM Hospital Mumbai, Christian Medical College Vellore, Sanjay Gandhi PGI Lucknow, JIPMER Puducherry, NIMS Hyderabad and NIMHANS Bengaluru — and at several private chains. Cost per session typically ranges from about ₹500 at a public-sector centre to ₹3,000 at a premium private one; many fetal medicine units now include counselling in the package after a high-risk result.

A counsellor will usually take a detailed three-generation family history (the pedigree), explain the specific finding in plain language, lay out the testing options and their detection rates, discuss what each possible result would mean, and connect the family to support groups or networks of others who have been through similar situations. This is especially valuable for inherited conditions like thalassemia, where both partners may be carriers.

If a Screen Comes Back High-Risk: The Decision Framework

A high-risk screening result is not a diagnosis. The first thing to do is, deliberately, nothing major — no decision needs to be made on the day the result arrives, and the standard pathway is built to give you time and space. The recommended next step is a counselling visit with your OB-GYN and, where available, a genetic counsellor, to understand exactly what your specific result means in terms of probability. From there, diagnostic confirmation is offered: CVS at 11–14 weeks or amniocentesis from 16 weeks.

If a diagnostic test confirms a serious chromosomal abnormality, or the anomaly scan confirms a major structural defect, a family faces a deeply personal decision. The Indian legal framework for considering termination on fetal-abnormality grounds is the Medical Termination of Pregnancy (MTP) Act, as amended in 2021. It allows termination up to 20 weeks on the opinion of one registered medical practitioner; up to 24 weeks on the opinion of two practitioners for specified categories (including substantial fetal abnormality); and beyond 24 weeks only with the approval of a State or Union Territory Medical Board, specifically for substantial fetal abnormality. The framework exists to give families with confirmed serious anomalies a legal, medically supervised pathway — not to encourage decisions based on screening results alone.

Whatever the decision, it is the family's to make, with full information, time to absorb it, access to counselling, and clinicians who treat the situation with seriousness and care. Many families continue pregnancies even after a confirmed serious diagnosis, planning delivery at a centre with the right paediatric subspecialty support and preparing emotionally and practically. Others, after careful thought, end the pregnancy within the legal framework. Both are valid, both deserve respect and support, and neither is the default. If you've experienced a loss along the way, our guide to miscarriage types and recovery covers the emotional and physical aftercare.

Pre-Conception Care: Preventing What Can Be Prevented

A meaningful share of birth defects can be prevented or reduced through care that begins before conception, not just during pregnancy. The single highest-yield intervention is folic acid: 400–800 micrograms daily, started at least 3 months before conception and continued through the first trimester, cuts the risk of neural tube defects by roughly 70%. For women with a previous neural-tube-defect pregnancy or on certain epilepsy medications, the recommended dose is higher — often 4–5 mg daily, under medical supervision. Our guide to folic acid before conception covers timing and dosing, and our prenatal vitamins comparison explains which Indian brands actually matter.

Other pre-conception steps with strong evidence:

When to See a Doctor

Screening is part of routine antenatal care, so most of these are scheduled appointments rather than emergencies — but don't skip them, and don't delay if a report flags something. Contact your OB-GYN or fetal medicine unit if:

Common Myths About Birth Defect Screening

Myth: A soft marker on the scan always means an anomaly

  • False. Soft markers are anatomical variants that occur commonly in normal babies. An isolated soft marker on an otherwise normal scan — especially a common one like an echogenic intracardiac focus or a choroid plexus cyst — usually doesn't change the picture.
  • Multiple soft markers together do raise the prior probability of a chromosomal condition more substantially. The right response is calm interpretation in context with the screening biochemistry, NIPT result and maternal age — not panic.

Myth: A normal screen guarantees a perfectly healthy baby

  • False. Screening covers defined conditions — chromosomal aneuploidies, neural tube defects, the structural defects visible on the anomaly scan. It doesn't screen for every possible condition, and it can't detect everything that may develop later.
  • Routine antenatal monitoring, third-trimester growth scans, careful labour and delivery care, and postnatal screening through programmes like the Rashtriya Bal Swasthya Karyakram all remain essential regardless of a normal screen.

Myth: Only older mothers need anomaly screening

  • False. The risk of Down syndrome does rise with maternal age, but most babies with Down syndrome are born to mothers under 35 — simply because most pregnancies happen in that age group.
  • Structural anomalies, neural tube defects and inherited single-gene disorders are not strongly age-related. The 18–22 week anomaly scan is recommended for every pregnancy, regardless of maternal age.

Myth: There's no point in screening if you wouldn't terminate

  • Partly true, partly false. If you're certain you would continue the pregnancy regardless, NIPT and CVS/amniocentesis may not change your path — and declining them is a valid choice.
  • But the anomaly scan still matters, because identifying a major structural defect in advance allows you to deliver at a hospital with the right paediatric surgical and neonatal intensive care — which can change outcomes for many treatable conditions.

Myth: NIPT or the anomaly scan can tell you the baby's sex

  • Technically possible, legally prohibited in India. The PC-PNDT Act bans disclosure of fetal sex by any prenatal test or scan, however the information is obtained. Compliant labs and clinics never share it.
  • Any lab or doctor offering to disclose fetal sex is breaking the law, and both the provider and the family requesting it face criminal penalties. The clinical purpose of screening in India is detecting medical conditions — not sex determination.

Frequently asked questions

Is the double marker test or NIPT better?

NIPT is more accurate — about 99% detection for Down syndrome versus 80–85% for the double marker — but it costs far more (roughly ₹15,000–₹35,000 versus around ₹500–₹4,000). The double marker is an excellent, affordable first screen, and many women only move to NIPT if the double marker is high-risk or if they have specific risk factors. Both are screening tests; neither confirms a diagnosis.

My scan showed a soft marker. Should I be worried?

Usually not. A soft marker is a common anatomical variant, not a diagnosis. An isolated soft marker on an otherwise normal scan — such as an echogenic intracardiac focus or a choroid plexus cyst — typically doesn't change anything, and many cysts resolve on their own by 24–28 weeks. Ask your doctor how it fits with your other results and what the plan is; it's often just a note and a repeat scan.

Can a screening test confirm that my baby has Down syndrome?

No. Screening tests (double marker, quadruple marker, NIPT) only give a probability. A high-risk result must be confirmed with a diagnostic test — CVS or amniocentesis — which samples fetal cells directly. No major decision should be made on a screening result alone.

Which scans are essential in an Indian pregnancy?

At minimum: the dating scan (8–10 weeks), the NT scan with double marker (11–13⁺⁶ weeks), and the level-2 anomaly/TIFFA scan (18–22 weeks). FOGSI treats the anomaly scan as essential in every pregnancy. NIPT and diagnostic tests are optional and depend on your risk factors and screening results.

Can any test in India tell me my baby's sex?

No compliant test or clinic will. The PC-PNDT Act prohibits disclosing fetal sex by any scan or test, and both the provider and anyone requesting it face criminal penalties. All antenatal screening in India is strictly for detecting medical conditions.

What's the single most important thing I can do to prevent birth defects?

Start folic acid (400–800 mcg daily) at least three months before conception and continue through the first trimester — it cuts neural tube defect risk by roughly 70%. Alongside that, control diabetes, thyroid and blood pressure before pregnancy, ensure rubella immunity, and get carrier screening if you have a relevant family or community background.

Sources